UNION therapeutics

Quick facts

Marketed products

• Negative Control
  A negative control is an inactive or placebo substance used in clinical trials to establish baseline effects and validate that observed outcomes are due to the active drug rather than other factors.
• Positive Control · Oncology
  Positive control drug used to validate the efficacy of other treatments.

Phase 2 pipeline

• ATx201 Gel 2%
• Orismilast modified release tablets

Phase 1 pipeline

• ATx201 dermal formulations 2%
• ATx201 Gel 4%

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• UNION therapeutics portfolio CI brief
• UNION therapeutics pipeline updates RSS